Bispecific tau antibodies with additional binding to C1q or alpha-synuclein
Wim Hendricus Quint, Irena Matečko‐Burmann, Irene Schilcher, Tina Löffler, Michael Schöll, Björn M. Burmann, Thomas Vogels
This paper develops bispecific antibodies targeting multiple pathological targets in tauopathies and shows they inhibit aggregation and complement pathway activation.
Journal of Alzheimer s Disease · Feb 13, 2021Peer-reviewedNeuroscience